Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

ERK1/2 Antikörper (pThr187, pTyr204)

Der Kaninchen Polyklonal Anti-ERK1/2-Antikörper wurde für WB, IHC (p) und IF validiert. Er ist geeignet, ERK1/2 in Proben von Human, Maus und Ratte zu detektieren.
Produktnummer ABIN197000

Kurzübersicht für ERK1/2 Antikörper (pThr187, pTyr204) (ABIN197000)

Target

Alle ERK1/2 (MAPK1/3) Antikörper anzeigen
ERK1/2 (MAPK1/3) (Mitogen-Activated Protein Kinase 1/3 (MAPK1/3))

Reaktivität

  • 185
  • 162
  • 156
  • 21
  • 21
  • 18
  • 7
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human, Maus, Ratte

Wirt

  • 139
  • 49
  • 4
Kaninchen

Klonalität

  • 133
  • 59
Polyklonal

Konjugat

  • 85
  • 9
  • 6
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 1
  • 1
  • 1
  • 1
Dieser ERK1/2 Antikörper ist unkonjugiert

Applikation

  • 140
  • 66
  • 51
  • 51
  • 45
  • 34
  • 25
  • 24
  • 20
  • 13
  • 6
  • 5
  • 4
  • 3
  • 1
Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (IF)
  • Bindungsspezifität

    • 58
    • 37
    • 30
    • 30
    • 16
    • 12
    • 12
    • 5
    • 4
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    pThr187, pTyr204

    Spezifität

    This antibody detects endogenous levels of p44/42 MAP Kinase only when phosphorylated at Tyrosine 204.

    Aufreinigung

    Affinity Chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.

    Immunogen

    The antiserum was produced against synthesized phosphopeptide derived from Human p44/42 MAP Kinase around the phosphorylation site of Tyrosine 204 (T-E-Yp-V-A).
  • Applikationshinweise

    Western Blot: 1/500approx. 1/1000. Immunohistochemistry: 1/50approx. 1/100. Immunofluorescence: 1/100approx. 1/200.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.

    Protokoll

    1. TETE HANNKEN, et al. (2000) Am Soc Nephrol 11: 1387-13972. Omar D. PerezNature et al. (2002) Biotechnology 20: 155 - 1623. Jingui Yu, et al. (2005) Anesth Analg 101: 315-3214. Hironobu Ihn et al. (2000) Immunology 165: 2149-2155

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    PBS (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % Sodium Azide as preservative and 50 % Glycerol as stabilizer.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handhabung

    Avoid repeated freezing and thawing.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Store the antibody (in aliquots) at -20 °C.
  • Target

    ERK1/2 (MAPK1/3) (Mitogen-Activated Protein Kinase 1/3 (MAPK1/3))

    Andere Bezeichnung

    ERK1 / ERK2

    Hintergrund

    Both p44 and p42 MAP kinases (Erk1 and Erk2) function in a protein kinase cascade that plays a critical role in the regulation of cell growth and differentiation. Activation of MAP kinases occurs through phosphorylation of threonine and tyrosine (202 and 204 of human MAP kinase [Erk1] or 183 and 185 of rat Erk2) at the sequence T*EY* by a single upstream MAP kinase kinase (MEK). Both kinases are known to weakly autophosphorylate on tyrosine.Synonyms: ERK-1/ERK-2, Extracellular signal regulated kinase 1/2, Insulin stimulated MAP2 kinase, MAPK1/MAPK2, Microtubule associated protein 2 kinase, Mitogen activated protein kinase 1/2/3, P42/P44-MAPK
Sie sind hier:
Chat with us!